Mastek has cancelled its Non-Deal Roadshow (NDR) with analysts and institutional investors that was scheduled for August 26, 2026.

The company issued the intimation on August 25, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This disclosure supersedes the earlier notice dated August 20, 2026, which had announced the engagement.

Cancellation details

The roadshow was originally planned to take place in Mumbai starting at 9:00 am. It was designed to facilitate direct interaction with the analyst and investor community through one-on-one and group meetings.

Reena Abhijit Raje, Company Secretary and Compliance Officer of Mastek Limited, confirmed the cancellation in the regulatory filing. The company stated that the event stands cancelled effective immediately.

Mastek Limited has completed the sale of a commercial building situated at Mahindra World City, SEZ, Chengalpattu, Chennai, for an aggregate consideration of ₹60 crore. The transaction was finalized on August 17, 2026, marking the conclusion of the agreement entered into earlier in the year.

The buyer is Caresoft Mobility Private Limited, an entity that does not belong to the promoter, promoter group, or group companies of Mastek. Consequently, the transaction does not fall within the purview of related party transactions. The company received the total consideration in two tranches, in accordance with the terms of the memorandum of understanding dated April 24, 2026.

Transaction details

The asset sold comprises a commercial building with an approximate built-up area of 1,57,233 sq ft, located on leased land admeasuring 15.50 acres. Below are the key particulars of the disposal as disclosed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory compliance

The sale is not part of a Scheme of Arrangement. Mastek stated that the disposal of the land and building does not attract the terms of Regulation 37A of the SEBI Listing Regulations, as it does not constitute an undertaking or substantially the whole of the undertaking of the company under Section 180(1)(a) of the Companies Act, 2013. The disclosure was made pursuant to Regulation 30 read with Schedule III of the Listing Regulations and SEBI circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

This intimation serves as an update to the company's earlier communication vide letter no. SEC/010/2026-27 dated April 24, 2026, regarding the proposed asset sale.